Five things for pharma marketers to know: Friday, August 26, 2016

Five things for pharma marketers to know: Friday, August 26, 2016

Sarah Jessica Parker cuts ties with Mylan over pricing controversy; lung-cancer physicians turn to Keytruda; Merck KGaA diversifies its business

Five things for pharma marketers to know: Thursday, August 25, 2016

Five things for pharma marketers to know: Thursday, August 25, 2016

Mylan offers additional copay assistance for EpiPen amid criticism; fewer doctors are seeing reps; two Copaxone patents are invalidated

Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market

Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market

The drugmaker expects the multi-channel initiative to lay its foundation in the ophthalmology market.

Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards

Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards

The anti-tobacco movement Truth is hitting young people in their pocketbooks with a new spot called "Squadless."

Five things for pharma marketers to know: Wednesday, August 24, 2016

Five things for pharma marketers to know: Wednesday, August 24, 2016

Retzlaff files a complaint against Turing; Pfizer to buy antibiotics from AstraZeneca; Mylan's marketing for EpiPen faces criticism

Five things for pharma marketers to know: Tuesday, August 23, 2016

Five things for pharma marketers to know: Tuesday, August 23, 2016

Grassley blasts Mylan over EpiPen price increases; Portola Pharmaceuticals receives CRL letter for reversal agent; the FDA approves Pfizer's opioid

In Medivation deal, Pfizer will gain an oncology blockbuster

In Medivation deal, Pfizer will gain an oncology blockbuster

Pfizer's commercial expertise in urology and oncology could help propel Medivation's Xtandi to new heights.

Five things for pharma marketers to know: Monday, August 22, 2016

Five things for pharma marketers to know: Monday, August 22, 2016

Pfizer to acquire cancer drugmaker Medivation; Valeant names new CFO; Apple acquires health data startup

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.

Five things for pharma marketers to know: Friday, August 19, 2016

Five things for pharma marketers to know: Friday, August 19, 2016

Another study finds doctors who receive gifts from drugmakers prescribe their drugs; Part D spending rose 17% in 2014; Mallinckrodt to open New Jersey site

Expect healthcare agencies to make more digital acquisitions: report

Expect healthcare agencies to make more digital acquisitions: report

Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.

Five things for pharma marketers to know: Thursday, August 18, 2016

Five things for pharma marketers to know: Thursday, August 18, 2016

Court clears Pfizer to move ahead with Remicade biosimilar; McDonald's yanks activity trackers over skin irritation; California drug-pricing bill pulled

Five things for pharma marketers to know: Wednesday, August 17, 2016

Five things for pharma marketers to know: Wednesday, August 17, 2016

AHIP study says half of orphan-drug usage is for non-orphan indications; Studies of GSK weight-loss pill underestimated side effects; ViiV starts HIV trial

Healthline's traffic rises, putting it closer to WebMD and Everyday Health

Healthline's traffic rises, putting it closer to WebMD and Everyday Health

The health site had a 44% increase in unique visitors in July 2016, compared to the same month a year ago.

Cleveland Clinic aims to get guys talking in first men's health campaign

Cleveland Clinic aims to get guys talking in first men's health campaign

The Cleveland Clinic has launched its first national men's health campaign, MENtion It, to encourage men to be more proactive about their health.

Drugmakers condemn ICER-funded study on PCSK9s

Drugmakers condemn ICER-funded study on PCSK9s

A new study published in JAMA said PCSK9 inhibitors are not worth their high prices.

Five things for pharma marketers to know: Tuesday, August 16, 2016

Five things for pharma marketers to know: Tuesday, August 16, 2016

OncoGenex's prostate cancer drug fails in clinical trial; Aetna to exit exchanges in 11 states; pregnant women taking acetaminophen have higher risks for their children

Lobbyists create off-label principles following FDA lawsuits

Lobbyists create off-label principles following FDA lawsuits

PhRMA and BIO, which represent life sciences firms, developed principles about sharing truthful and non-misleading information with payers and providers.

One year on: Inside Bayer's effort to get prostate cancer patients to speak up

One year on: Inside Bayer's effort to get prostate cancer patients to speak up

Bayer recently tapped Ken Griffey Sr. and Ken Griffey Jr. — the first father-son duo to be inducted into the Baseball Hall of Fame — as spokespeople.

Healthcare agencies not immune to gender bias, parity issues

Healthcare agencies not immune to gender bias, parity issues

Agencies are testing out strategies to reach gender parity at a time when questions of discrimination are still front and center.

Five things for pharma marketers to know: Monday, August 15, 2016

Five things for pharma marketers to know: Monday, August 15, 2016

Express Scripts does not disclose names of formulary board members; Endo withdrew abuse-deterrent formulation for opioid; BI to collect real-world data on Praxbind

DTC ads for Opdivo face further backlash

DTC ads for Opdivo face further backlash

Critics say the direct-to-consumer ad for the immuno-oncology therapy is misleading.

Johnson & Johnson's Alison Lewis on building memorable brands

Johnson & Johnson's Alison Lewis on building memorable brands

The company's first global consumer CMO shares the challenges of delivering global campaigns and meeting local market needs.

Five things for pharma marketers to know: Friday, August 12, 2016

Five things for pharma marketers to know: Friday, August 12, 2016

Study finds estimated drug costs are often overstated; physician criticizes DTC ad for Opdivo; Merck HPV ads are criticized for being manipulative

Five things for pharma marketers to know: Thursday, August 11, 2016

Five things for pharma marketers to know: Thursday, August 11, 2016

Valeant is under federal investigation; Lilly's breast-cancer drug fails to meet efficacy criteria; new policy opens up medical research of marijuana

Analysts: Payers moving to address MS market as prices rise

Analysts: Payers moving to address MS market as prices rise

The impending payer crackdown of the cost of MS drugs could portend the fate of other specialty drug markets, according to analysts.

W2O faces gender discrimination suit from former staffer

W2O faces gender discrimination suit from former staffer

Lynn Fox is suing W2O. She was laid off in March, seven months after the agency network bought her San Francisco-based boutique, Fox Communications.

Five things for pharma marketers to know: Wednesday, August 10, 2016

Five things for pharma marketers to know: Wednesday, August 10, 2016

A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion

Valeant salesforce stabilizes as Xifaxan rebounds

Valeant salesforce stabilizes as Xifaxan rebounds

Valeant had deployed roughly 100 additional sales reps this year to promote Xifaxan's indication in hepatic encephalopathy.

Verywell and Cleveland Clinic to partner on health content site

Verywell and Cleveland Clinic to partner on health content site

The companies said they are also exploring opportunities to allow Cleveland Clinic experts to contribute to Verywell in the future.

Five things for pharma marketers to know: Tuesday, August 9, 2016

Five things for pharma marketers to know: Tuesday, August 9, 2016

Novo Nordisk attributes slow growth to biosimilars, pricing; Dentsu acquires majority stake in Merkle; AZ lung cancer drug fails late-stage trial

Opdivo bet backfires, creates opening for Merck to pursue DTC

Opdivo bet backfires, creates opening for Merck to pursue DTC

A massive disappointment for Bristol-Myers Squibb's Opdivo in first-line lung cancer has leveled the playfield for Merck's Keytruda.

Five things for pharma marketers to know: Monday, August 8, 2016

Five things for pharma marketers to know: Monday, August 8, 2016

Valeant reorganizes executive team; experimental asthma drug developed by Novartis shows promising results; Teva launches generic Gleevec

Event company acquires AstraZeneca's medical meetings app

Event company acquires AstraZeneca's medical meetings app

The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.

Five things for pharma marketers to know: Friday, August 5, 2016

Five things for pharma marketers to know: Friday, August 5, 2016

Opdivo fails to meet endpoint in new lung cancer patients; abuse-deterrent drug gets nod from FDA panel; Cephalon settles pay-for-delay case

Cigna's first global brand campaign targets expats

Cigna's first global brand campaign targets expats

The campaign will run in an integrated digital marketing format using channels such as Facebook, Twitter, and Youtube.

Five things for pharma marketers to know: Thursday, August 4, 2016

Five things for pharma marketers to know: Thursday, August 4, 2016

Researchers test Zika vaccine; Aetna contacts doctors who prescribe high rates of opioids; half of pediatric trials are never published or completed

Fitbit hires Walgreens exec as digital health VP

Fitbit hires Walgreens exec as digital health VP

The popular fitness tracker maker hired Adam Pellegrini, Walgreens' VP of digital health, to boost pharma and healthcare deals.

PBMs unveil 2017 formularies, retain focus on exclusions

PBMs unveil 2017 formularies, retain focus on exclusions

Express Scripts and CVS Health revealed their formularies with Pfizer's Xeljanz making the jump from excluded to preferred for Express Scripts.

Five things for pharma marketers to know: Wednesday, August 3, 2016

Five things for pharma marketers to know: Wednesday, August 3, 2016

Merck and Allergan reportedly vying to buy Biogen; drugmakers fight California measure capping drug prices; few seniors use the web to look for health info

Philips launches health watch and 3 other connected devices

Philips launches health watch and 3 other connected devices

The company launched a health watch, a connected scale, a blood pressure monitor, and a thermometer.

Kevin Roberts resigns from Saatchi & Saatchi after gender diversity controversy

Kevin Roberts resigns from Saatchi & Saatchi after gender diversity controversy

He resigned as Saatchi & Saatchi's executive chairman following his controversial remarks over gender diversity.

Five things for pharma marketers to know: Tuesday, August 2, 2016

Five things for pharma marketers to know: Tuesday, August 2, 2016

IBM develops chip to detect early stages of cancer; Theranos plans to develop a "minilab;" Aetna and Humana to sell $117 million in assets

Healthcare marketers still pushing to address the gender gap

Healthcare marketers still pushing to address the gender gap

MM&M's 2016 Hall of Femme honorees talk about who inspires them, describe their "Raphael moments," and share their experiences as women leaders.

Video: MM&M's Hall of Femme

Video: MM&M's Hall of Femme

Here's everything you missed or may want to revisit from MM&M's inaugural Hall of Femme event in June.

Saatchi's Roberts placed on leave for comments on gender diversity

Saatchi's Roberts placed on leave for comments on gender diversity

The reaction from social media was swift and brutal, with figures from all levels of the advertising industry blasting Roberts for his comments.

DDB brings delegates face to face with realities of addiction

DDB brings delegates face to face with realities of addiction

By focusing on accomplished people, the campaign is meant to show that addiction isn't a moral failing, but a physical condition that requires medical help.

Five things for pharma marketers to know: Monday, August 1, 2016

Five things for pharma marketers to know: Monday, August 1, 2016

GSK partners with Google to create joint venture; Philips Healthcare launches a health watch; Advent invests in inVentiv Health

Five things for pharma marketers to know: Friday, July 29, 2016

Five things for pharma marketers to know: Friday, July 29, 2016

England's NHS delays hep-C coverage due to pricing; Google reports 21% revenue growth; U.S. and U.K. announce partnership for antibiotic development

Five things for pharma marketers to know: Thursday, July 28, 2016

Five things for pharma marketers to know: Thursday, July 28, 2016

Vertex says Orkambi is on the blockbuster track; Advent and CVC reportedly made offers to buy inVentiv Health; the FDA approves Sanofi's Adlyxin

W2O names Gillespie chief strategy officer of medtech practice

W2O names Gillespie chief strategy officer of medtech practice

She will be responsible for the medical device practice's strategy and operations across all W2O Group agencies.

Five things for pharma marketers to know: Wednesday, July 27, 2016

Five things for pharma marketers to know: Wednesday, July 27, 2016

IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire

Five things for pharma marketers to know: Tuesday, July 26, 2016

Five things for pharma marketers to know: Tuesday, July 26, 2016

Sales of Gilead's HCV drugs fall; the DNC policy platform criticized price gouging; Janssen partners with Bristol-Myers Squibb on Opdivo combo drug

Huntsworth Health revenue rose 18% in the first half of 2016

Huntsworth Health revenue rose 18% in the first half of 2016

Red, a Huntsworth agency, also counted Sanofi as a new client.

M Booth supports Leukemia & Lymphoma Society's Light the Night campaign

M Booth supports Leukemia & Lymphoma Society's Light the Night campaign

The nonprofit is dedicated to curing blood cancer.

GSK Consumer Healthcare to prioritize digital after agency review

GSK Consumer Healthcare to prioritize digital after agency review

Now that it has consolidated its global agency roster, GSK Consumer Healthcare aims to increase digital marketing efforts.

Five things for pharma marketers to know: Monday, July 25, 2016

Five things for pharma marketers to know: Monday, July 25, 2016

Darzalex may interfere with blood testing; Kaine scrutinized for ties to pharma; medical societies are in support of bill exempting CME reporting

Five things for pharma marketers to know: Friday, July 22, 2016

Five things for pharma marketers to know: Friday, July 22, 2016

Herceptin biosimilar meets endpoint in clinical trial; Roche plans to launch five new drugs over the next year; government seeks to block insurer deals

Biogen ends Tecfidera DTC campaign, citing prescriptions

Biogen ends Tecfidera DTC campaign, citing prescriptions

The drugmaker had launched the campaign for the multiple sclerosis drug in 2015.

Five things for pharma marketers to know: Thursday, July 21, 2016

Five things for pharma marketers to know: Thursday, July 21, 2016

The FDA approves generic versions of AstraZeneca's Crestor; Biogen CEO steps down; drugmakers race to develop smart inhalers

Five things for pharma marketers to know: Wednesday, July 20, 2016

Five things for pharma marketers to know: Wednesday, July 20, 2016

Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger

Novartis ups marketing investment in Entresto, by $200 million

Novartis ups marketing investment in Entresto, by $200 million

One oft-cited challenge to Entresto's adoption has been prior authorization requirements.

Why competing agencies are joining forces to give parents more time off

Why competing agencies are joining forces to give parents more time off

Twenty shops, including Co:Collective, Wolff Olins, and 72andSunny, have signed onto the Pledge Parental Leave coalition since March.

Five things for pharma marketers to know: Tuesday, July 19, 2016

Five things for pharma marketers to know: Tuesday, July 19, 2016

The FDA declines to approve Novartis biosimilar; GSK partners with Apple's ResearchKit; drugmakers partner with Lyft for clinical trial participants

ZS' Pete Mehr on embracing and adapting to change

ZS' Pete Mehr on embracing and adapting to change

Mehr was recently promoted to lead customer-centric marketing solutions at ZS Associates.

Five things for pharma marketers to know: Monday, July 18, 2016

Five things for pharma marketers to know: Monday, July 18, 2016

Roche's blood cancer drug fails to meet trial goal; the FDA says Valeant's psoriasis drug carries risk of suicide; Facebook tests disappearing messages

At Work With: ContextMedia:Health's Ashik Desai

At Work With: ContextMedia:Health's Ashik Desai

The health technology company's EVP of business growth and analytics talks about his career path, from studying medicine to leading ContextMedia:Health's commercial solutions team.

Five things for pharma marketers to know: Friday, July 15, 2016

Five things for pharma marketers to know: Friday, July 15, 2016

PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit

Arnold's Gary Scheiner to lead creative at ghg

Arnold's Gary Scheiner to lead creative at ghg

Scheiner has held jobs in and out of healthcare over the course of his career.

Five things for pharma marketers to know: Thursday, July 14, 2016

Five things for pharma marketers to know: Thursday, July 14, 2016

The FDA expands use for Pfizer's Prevnar 13 vaccine; an FDA panel votes in support of Novartis biosimilar; U.S. healthcare spending rises 5.5% in 2015

Asia-Pacific to overtake North America in ad spending

Asia-Pacific to overtake North America in ad spending

Globally, digital ad spend this year is expected to grow by 12.6% to $176.7 billion, accounting for 32% of all ad spend.

Five things for pharma marketers to know: Wednesday, July 13, 2016

Five things for pharma marketers to know: Wednesday, July 13, 2016

Gilead reportedly avoiding paying billions in taxes; Merck plans to cut R Sage's treatment for postpartum depression meets trial goal

Digitas Health LifeBrands partners with startup accelerator Dreamit

Digitas Health LifeBrands partners with startup accelerator Dreamit

The partnership is aimed at helping later-stage health startups grow their businesses with marketing and brand strategy advice.

Five things for pharma marketers to know: Tuesday, July 12, 2016

Five things for pharma marketers to know: Tuesday, July 12, 2016

U.S. cancer centers triple spending on advertising; study finds patient choice can reduce side effects; the FDA approves Shire's dry-eye drug

Astellas hires Joseph Devaney as government affairs VP

Astellas hires Joseph Devaney as government affairs VP

He is replacing Martin Golden, who was appointed head of global marketing strategy.

Five things for pharma marketers to know: Monday, July 11, 2016

Five things for pharma marketers to know: Monday, July 11, 2016

Purdue Pharma reportedly knew about OxyContin trafficking; Amgen's Repatha approved for monthly dosing option; Clinton proposes new healthcare measures

Are you a finalist in the MM&M Awards? Find out now

Are you a finalist in the MM&M Awards? Find out now

Work created by the FCB Health network and Ogilvy CommonHealth Worldwide named among the finalists for the 2016 MM&M Awards.

Prounis describes her decision to sell Flashpoint stake as personal

Prounis describes her decision to sell Flashpoint stake as personal

Prounis sold her stake in Flashpoint to Omnicom, which is merging the agency with four other shops to create DDB Health.

Five things for pharma marketers to know: Friday, July 8, 2016

Five things for pharma marketers to know: Friday, July 8, 2016

The FDA said Amgen's biosimilar of Humira is safe and effective; Juno trial halted due to patient deaths; the CMS bans Theranos founder

Can pharma movement campaigns flourish on both sides of the Atlantic?

Can pharma movement campaigns flourish on both sides of the Atlantic?

Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.

Five things for pharma marketers to know: Thursday, July 7, 2016

Five things for pharma marketers to know: Thursday, July 7, 2016

EpiPen price hikes led to syringe use; states with medical marijuana laws have drops in drug spending; Pfizer and Merck KGaA start ovarian cancer trial

Five things for pharma marketers to know: Wednesday, July 6, 2016

Five things for pharma marketers to know: Wednesday, July 6, 2016

Pfizer to disclose addiction risk in promo materials for opioids; Medivation considers an acquisition; Almirall expresses interest in buying Valeant drugs

Cancer detection tool among projects chosen for Publicis90 initiative

Cancer detection tool among projects chosen for Publicis90 initiative

U.S. companies accounted for nearly a quarter of the startups funded to celebrate Publicis' 90th anniversary.

Five things for pharma marketers to know: Tuesday, July 5, 2016

Five things for pharma marketers to know: Tuesday, July 5, 2016

States and insurers are lifting restrictions on HCV drugs; Teva's request to join PhRMA raises eyebrows; Merck partners with GPO

The top 100 healthcare agencies, ranked by 2015 revenue

The top 100 healthcare agencies, ranked by 2015 revenue

Ogilvy CommonHealth Worldwide, FCB Health, and McCann Health North America are North America's biggest healthcare agencies, based on 2015 revenue.

Five things for pharma marketers to know: Friday, July 1, 2015

Five things for pharma marketers to know: Friday, July 1, 2015

Drugmakers doled out $452 million to UK healthcare providers; GSK, Pfizer see big market in vaccines for expectant mothers; Shire ADHD drug meets endpoint

Five things for pharma marketers to know: Thursday, June 30, 2016

Five things for pharma marketers to know: Thursday, June 30, 2016

BI axes 725 U.S. jobs; Bill Gates supports current U.S. drug pricing; drugmakers are targeting smaller hospitals

Hotwire launches global health tech practice for predicted $43bn market

Hotwire launches global health tech practice for predicted $43bn market

Global tech PR agency Hotwire has launched a global health tech practice, overseen from London by group chief development officer Andy West.

Are you happy with your paycheck?

Are you happy with your paycheck?

Help us compile the most accurate and meaningful picture of salaries, job satisfaction, and trends in the healthcare market. And be entered to win one of three $200 AmEx gift cards.

Five things for pharma marketers to know: Wednesday, June 29, 2016

Five things for pharma marketers to know: Wednesday, June 29, 2016

GIlead Sciences' new HCV treatment receives approval; FDA adcomm votes in favor of Jardiance health-outcomes' claims; FDA names head of new oncology center

Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health

Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health

The new healthcare network combines several US and European professional agencies, Omnicom said.

Five things for pharma marketers to know: Tuesday, June 28, 2016

Five things for pharma marketers to know: Tuesday, June 28, 2016

Opdivo nets sixth Breakthrough Therapy designation; AstraZeneca seeks rare indication to block Crestor generics; Endo mulls sale to reduce debt

Valeant LGBTQ campaign seeks to avoid stereotypes

Valeant LGBTQ campaign seeks to avoid stereotypes

Tactics like a talking bear were employed to engage the LGBTQ community and millennials, along with a tagline promoting self-expression.

Five things for pharma marketers to know: Monday, June 27, 2016

Five things for pharma marketers to know: Monday, June 27, 2016

Former FDA commissioners said agency should be independent from HHS; Sanofi and BI confirm asset swap; FDA panel to vote on new Jardiance data

Five things for pharma marketers to know: Friday, June 24, 2016

Five things for pharma marketers to know: Friday, June 24, 2016

Brexit votes creates EU regulatory uncertainty; Obama plans to veto health saving accounts bill; broad Entresto adoption could prevent more than 28,000 deaths

Five things for pharma marketers to know: Thursday, June 23, 2016

Five things for pharma marketers to know: Thursday, June 23, 2016

Medicare cost-cutting panel will not be activated this year; more Americans are abusing opioids; BIO blasts ICER

Razorfish Health names new managing director

Razorfish Health names new managing director

David Paragamian, previously of Huntsworth Health, is the new managing director of Razorfish Health.

Non-profit behind Free Killer Tan wants parents to practice sun safety

Non-profit behind Free Killer Tan wants parents to practice sun safety

Mr. Sun serves as a follow-up to last year's social media campaign Free Killer Tan, and looks to encourage "UV-smart behaviors" among parents.

Five things for pharma marketers to know: Wednesday, June 22, 2016

Five things for pharma marketers to know: Wednesday, June 22, 2016

Women use apps to get prescriptions for birth control; BMS names Gordon to chief commercial role; Takeda's Actos may halt progression of liver disease;

Ruder Finn hires Sally Barton to lead U.S. healthcare, creates new role for Susan Goldstein

Ruder Finn hires Sally Barton to lead U.S. healthcare, creates new role for Susan Goldstein

The agency has hired Sally Barton as head of the U.S. healthcare practice/

OPINION

Email Newsletters